Mendel.ai was founded with the mission to streamline global oncology research through the use of novel AI technology aided by clinical experts. The company's vision is to revolutionize the clinical trial process by organizing real-world data and automating various stages of clinical trials. Mendel.ai offers a suite of AI-powered software solutions including Clinical Data Abstraction, Clinical Record OCR, PHI De-identification, Clinical Search Engine, Clinical Trial Matching, and Clinical Data Assets. These products aim to simplify the complexities of clinical data management and enhance the efficiency of clinical trials.
Notable figures affiliated with Mendel.ai include Leslie Lamport, a Turing Award winner, and Melisa Tucker, VP of Product Management & Operations at Flatiron. The company has achieved significant milestones in the field of AI and clinical research, contributing to more efficient and accurate data handling in oncology trials. Mendel.ai's impact is evident in its ability to transform clinical trial processes, making them more streamlined and accessible, thus accelerating the pace of medical research and development.